STAAR/$STAA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About STAAR
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
Ticker
$STAA
Sector
Primary listing
Employees
1,157
Headquarters
Website
STAAR Metrics
BasicAdvanced
$1.2B
-
-$1.95
1.01
-
Price and volume
Market cap
$1.2B
Beta
1.01
52-week high
$30.81
52-week low
$13.50
Average daily volume
798K
Financial strength
Current ratio
5.211
Quick ratio
4.101
Long term debt to equity
9.555
Total debt to equity
11.057
Profitability
EBITDA (TTM)
-53.793
Gross margin (TTM)
73.87%
Net profit margin (TTM)
-41.79%
Operating margin (TTM)
-27.10%
Effective tax rate (TTM)
-4.81%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
-7.88%
Return on equity (TTM)
-24.65%
Valuation
Price to revenue (TTM)
5.047
Price to book
3.28
Price to tangible book (TTM)
3.56
Price to free cash flow (TTM)
-29.433
Free cash flow yield (TTM)
-3.40%
Free cash flow per share (TTM)
-0.8
Growth
Revenue change (TTM)
-32.42%
Earnings per share change (TTM)
-543.26%
3-year revenue growth (CAGR)
-6.19%
10-year revenue growth (CAGR)
12.23%
3-year earnings per share growth (CAGR)
36.31%
10-year earnings per share growth (CAGR)
24.94%
What the Analysts think about STAAR
Analyst ratings (Buy, Hold, Sell) for STAAR stock.
STAAR Financial Performance
Revenues and expenses
STAAR Earnings Performance
Company profitability
STAAR News
AllArticlesVideos
Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process
Business Wire·19 hours ago
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
Business Wire·1 day ago
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
Business Wire·7 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for STAAR stock?
STAAR (STAA) has a market cap of $1.2B as of December 09, 2025.
What is the P/E ratio for STAAR stock?
The price to earnings (P/E) ratio for STAAR (STAA) stock is 0 as of December 09, 2025.
Does STAAR stock pay dividends?
No, STAAR (STAA) stock does not pay dividends to its shareholders as of December 09, 2025.
When is the next STAAR dividend payment date?
STAAR (STAA) stock does not pay dividends to its shareholders.
What is the beta indicator for STAAR?
STAAR (STAA) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.